Trials / Recruiting
RecruitingNCT05440240
Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture
Percutaneous Needle Fasciotomy (PNF) +/- Corticosteroid Injection for Dupuytren's Contracture (DC) Affecting Metacarpophalangeal Joints (MCP) . A Randomized Controlled Trial
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Regionshospitalet Silkeborg · Academic / Other
- Sex
- All
- Age
- 45 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Comparing percutaneous needle fasciotomy +/- corticosteroid injection for Dupuytren's contracture affecting metacarpophalangeal joints. A clinician-initiated, multicenter, randomized controlled trial.
Conditions
- Dupuytren Contracture
- Dupuytren's Disease
- Contracture
- Joint Diseases
- Musculoskeletal Diseases
- Fibroma
- Neoplasm, Fibrous Tissue
- Neoplasms, Connective Tissue
- Neoplasms, Connective and Soft Tissue
- Neoplasms by Histologic Type
- Neoplasms
- Connective Tissue Diseases
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Percutaneous needle fasciotomy | Percutaneous needle fasciotomy ad modum Lermusiaux and Debeyre |
| DRUG | Corticosteroid injection | Depo-Medrol |
| OTHER | Saline injection | Isotonic saline |
Timeline
- Start date
- 2023-01-10
- Primary completion
- 2025-12-01
- Completion
- 2030-03-01
- First posted
- 2022-06-30
- Last updated
- 2023-05-17
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05440240. Inclusion in this directory is not an endorsement.